Allogene Therapeutics, Inc.
Asset & Liabilities Breakdown
Asset Breakdown FY2022
Total Assets: $821.6M
Liabilities Breakdown FY2022
Total Liabilities: $154.7M
Asset Breakdown
Total Assets: $821.6M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $61.9M | 7.5% |
| Accounts Receivable | $0 | 0.0% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $112.8M | 13.7% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $646.8M | 78.7% |
Liabilities Breakdown
Total Liabilities: $154.7M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $13.9M | 9.0% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $140.8M | 91.0% |